
5G Care Pharma Private Limited
About 5G Care Pharma Private Limited
Data last updated:
5G Care Pharma Private Limited is a private limited company based in Coimbatore, Tamil Nadu, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 October 2022.
The company is registered with the Registrar of Companies (ROC), Coimbatore, under CIN U51909TZ2022PTC040117.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Mohan Hanuyudhish and Mohan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at P 706 Purva Bluemont Appartment Trichy Road Singanallur, Coimbatore, Tamil Nadu, India – 641005.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.47 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹1.46 Lakh (net margin 1%) and EBITDA of ₹3.22 Lakh (EBITDA margin 2.2%).
Company details
Contact details
5G Care Pharma Private Limited's registered office is in Coimbatore, Tamil Nadu.
- Registered AddressP 706 Purva Bluemont Appartment Trichy Road Singanallur, Coimbatore, Tamil Nadu, India – 641005
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of 5G Care Pharma Private Limited
FY 2025 filings available5G Care Pharma Private Limited reported revenue of ₹1.47 Cr (up 273% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 273% in the latest year. EBITDA rose 180% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹3.22 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹1.46 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 2.2% | ||
| Net Profit Margin | 1% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of 5G Care Pharma Private Limited, buy the company report.
Board of directors of 5G Care Pharma Private Limited
5G Care Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mohan Hanuyudhish | Director | 13 Oct 2022 | 4 Years 1 Months | Current |
| Mohan | Director | 13 Oct 2022 | 4 Years 1 Months | Current |
Peer comparison
5G Care Pharma Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Focus Pharma Private Limited | ₹1.47 Cr (FY 2025) | -5.0% | Ahmedabad, Gujarat, India | |||
| Paras Laboratories Limited | ₹1.47 Cr (FY 2024) | 7.0% | Chandigarh, India | |||
| Dwaai Private Limited | ₹1.47 Cr (FY 2025) | 65.0% | Panchkula, Haryana, India | |||
| Pharmiza Drugs Private Limited | ₹1.47 Cr (FY 2025) | 25.0% | Indore, Madhya Pradesh, India | |||
| Ramsey Pharma Pvt Ltd | ₹1.47 Cr (FY 2025) | 14.0% | Kolkata, West Bengal, India | |||
| 5G Care Pharma Private Limitedthis company | ₹1.47 Cr (FY 2025) | ₹1.46 Lakh | 1% | 273.0% | Coimbatore, Tamil Nadu, India | |
| Sthree Pharmaceuticals Private Limited | ₹1.46 Cr (FY 2024) | -69.0% | Chennai, Tamil Nadu, India | |||
| KMRS Pharma Private Limited | ₹1.46 Cr (FY 2025) | 82.0% | Ahmedabad, Gujarat, India | |||
| Jagbir Pharmaceuticals Private Limited | ₹1.46 Cr (FY 2023) | 221.0% | Rohtak, Haryana, India | |||
| Stevia Pharmaceuticals Private Limited | ₹1.46 Cr (FY 2025) | -8.0% | Secunderabad, Telangana, India | |||
| Primco Private Limited | ₹1.46 Cr (FY 2025) | -11.0% | Patna, Bihar, India |
To see the full peer comparison of 5G Care Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving 5G Care Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for 5G Care Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for 5G Care Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
5G Care Pharma Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Mohan was appointed as Director on 13 Oct 2022.
Frequently asked questions
5G Care Pharma is an active private limited company based in Coimbatore, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 13 October 2022 (4+ years old) and is registered under CIN U51909TZ2022PTC040117.
5G Care Pharma has 2 current directors:
- Mohan Hanuyudhish - Director
- Mohan - Director
The latest financial statements of 5G Care Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of 5G Care Pharma is U51909TZ2022PTC040117. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
5G Care Pharma was incorporated on 13 October 2022, making it 4+ years old. It is registered with the Registrar of Companies, Coimbatore.
The peers of 5G Care Pharma by revenue are Focus Pharma Private Limited, Paras Laboratories Limited, Dwaai Private Limited, Pharmiza Drugs Private Limited, Ramsey Pharma Pvt Ltd and 5 more, all in the Pharma industry (Formulations).
Mohan was appointed as Director on 13 Oct 2022. Mohan Hanuyudhish was appointed as Director on 13 Oct 2022.
The registered office of 5G Care Pharma is at P 706 Purva Bluemont Appartment Trichy Road Singanallur, Coimbatore, Tamil Nadu, India – 641005.
5G Care Pharma operates in the pharma industry, in the drug formulation and development segment.
5G Care Pharma can be reached at its registered office: P 706 Purva Bluemont Appartment Trichy Road Singanallur, Coimbatore, Tamil Nadu, India – 641005.
5G Care Pharma is registered under the jurisdiction of the Registrar of Companies (ROC), Coimbatore.

